SMis 9th annual Controlled Release

Venue: -

Location: -

Event Date/Time: Mar 28, 2012 End Date/Time: Mar 28, 2012
Early Registration Date: Dec 17, 2011
Report as Spam


SMi’s ninth annual conference on Controlled-Release features new presentation from leading companies in this exciting field. Examining the latest developments in nanomedicine, topics include innovative drug delivery vehicles for extended-release therapies, and formulating poorly water-soluble compounds.

New for 2012, Lundbeck showcase how to effectively utilise in silico tools from discovery to the clinic.

This is the perfect opportunity to network with key decision makers, key experts and your peers in the field to gain a focused overview of the key developments from 2011 and 2012.

Critical challenges being addressed include:

• Oral delivery of peptides and proteins, including GLP-1 analogues and insulin

• Improving oral, lipid-based formulations

• Optimising in vivo dissolution rate kinetics

• Delivering CNS-targeted biologics

Hear addresses from:

• Mario Maio, Director of Formulation & Process Development, Merck Serono
• Mostafa Nakach, Head of the Pharmaceutical Engineering Group, Sanofi-Aventis
• Elaine Merisko-Liversidge, Senior Director, Alkermes
• Karin Liltorp, Director, Preformulation, Lundbeck



Additional Information

PLUS TWO HALF-DAY PRE-CONFERENCE WORKSHOPS ON Accelerating first-in-human studies (FIH) with lipid-based formulations Tuesday 27th March 2012, 8:30 am – 12:30 pm In association with Capsugel, Gattefossé, Hauss Associates A trip through the life and work of a patent Tuesday 27th March 2012, 1:30 pm – 5:30pm In association with Harrison Goddard Foote (HGF), and HGF Law